Pfizer Announces Submission of New Drug Application to the U.S. FDA for Paxlovid
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk for progression to severe illness from COVID-19; consistent with current emergency use authorization
Final results from EPIC-HR...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news
More News: Covid Vaccine | COVID-19 | Drugs & Pharmacology | Emergency Medicine | New Drug Applications | Pfizer | Vaccines